MANTELLE JUAN A 4
4 · NOVEN PHARMACEUTICALS INC · Filed Jan 25, 2005
Insider Transaction Report
Form 4
MANTELLE JUAN A
VP and Chief Technical Officer
Transactions
- Exercise/Conversion
Common Stock ($.0001 Par Value)
2005-01-21$8.67/sh+652$5,653→ 21,846 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-01-21−652→ 0 totalExercise: $8.67Exp: 2005-01-21→ Common Stock ($.0001 Par Value) (652 underlying)
Footnotes (1)
- [F1]10% exercisable after 1/21/1999; 20% exercisable after 1/21/2000; 20% exercisable after 1/21/2001; 25% exercisable after 1/21/2002; 25% exercisable after 1/21/2003.